Statement Of Financial Position [Abstract]

Transgene - Filing #6250839

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Intangible assets other than goodwill
62,000 EUR
80,000 EUR
Cash and cash equivalents
16 670 EUR
15 666 EUR
4 403 EUR
Assets
42 174 EUR
45 217 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
66 147 EUR
50 426 EUR
Equity attributable to owners of parent
15 204 EUR
15 612 EUR
Equity
105 760 EUR
88 711 EUR
66 147 EUR
522,000 EUR
15 203 EUR
446,000 EUR
33 971 EUR
15 612 EUR
83 432 EUR
22 328 EUR
432,000 EUR
71 156 EUR
50 426 EUR
642,000 EUR
37 841 EUR
50 628 EUR
32 804 EUR
808,000 EUR
450,000 EUR
70 813 EUR
50 102 EUR
Liabilities [abstract]
Liabilities
26 970 EUR
29 605 EUR
Equity and liabilities
42 174 EUR
45 217 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.